Metastasectomy after targeted therapy in patients with advanced renal cell carcinoma Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Combined Chemotherapy Protocols
  • Carcinoma, Renal Cell
  • Kidney Neoplasms
  • Neoplasms, Multiple Primary
  • Nephrectomy

abstract

  • In a cohort of select patients with a limited tumor burden after treatment with targeted agents consolidative metastasectomy is feasible with acceptable morbidity. Significant time off targeted therapy and long-term tumor-free status are possible with this approach.

publication date

  • February 2011

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC4668716

Digital Object Identifier (DOI)

  • 10.1016/j.juro.2010.09.086

PubMed ID

  • 21167518

Additional Document Info

start page

  • 439

end page

  • 44

volume

  • 185

number

  • 2